English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduIn a letter to the U.S. Food and Drug Administration (FDA), the American Society of Anesthesiologists (ASA) expressed its strong support of naloxone nasal spray products for non-prescription use. Naloxone, a safe life-saving medication that rapidly reverses an opioid overdose and significantly reduces the incidence of opioid overdose deaths, should be available to all patients across the United States as a nonprescription treatment, according to the ASA.
Tag: Opioid Treatment
How the Pandemic Limited Access to Opioid Addiction Treatment for Racial and Ethnic Minority Groups
Members of racial and ethnic minority groups were less likely to obtain prescriptions to treat opioid addiction during the COVID-19 pandemic, according to a study by researchers at Rutgers and Indiana University.
Supervised Injection Site Ruling: Rutgers Expert Available to Discuss
Rutgers scholar Jamey Lister, an expert in opioid-related issues and barriers to treatment, is available to discuss the ruling that a supervised injection site would violate federal law. 3rd U.S. Circuit Court of Appeals issued a 2-1 ruling against the…
February 2021 highlights from AJPH
Highlights from February 2021 Issue of AJPH